Last reviewed · How we verify

NS infusion — Competitive Intelligence Brief

NS infusion (NS infusion) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Crystalloid fluid / Electrolyte replacement. Area: Supportive Care / Fluid Management.

marketed Crystalloid fluid / Electrolyte replacement Supportive Care / Fluid Management Small molecule Live · refreshed every 30 min

Target snapshot

NS infusion (NS infusion) — Seoul National University Hospital. NS infusion is a normal saline (0.9% sodium chloride) intravenous fluid that restores intravascular volume and maintains electrolyte balance.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
NS infusion TARGET NS infusion Seoul National University Hospital marketed Crystalloid fluid / Electrolyte replacement
Normal Saline 0.9% Infusion Solution Bag Normal Saline 0.9% Infusion Solution Bag Vanderbilt University Medical Center marketed Crystalloid fluid / Electrolyte replacement solution
Saline IV Saline IV Rhode Island Hospital marketed Crystalloid fluid / Electrolyte replacement
Saline solution isotonic 0.9% NaCl Saline solution isotonic 0.9% NaCl Krankenhaus Barmherzige Schwestern Linz marketed Crystalloid fluid / Electrolyte replacement solution
% 0.9 Saline solution % 0.9 Saline solution Kecioren Education and Training Hospital marketed Crystalloid fluid / Electrolyte replacement solution
Sterile isotonic saline solution Sterile isotonic saline solution Hospital Italiano de Buenos Aires marketed Crystalloid fluid / Electrolyte replacement solution
Isotonic NaCl Isotonic NaCl Hvidovre University Hospital marketed Crystalloid fluid / Electrolyte replacement solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Crystalloid fluid / Electrolyte replacement class)

  1. University of Auckland, New Zealand · 2 drugs in this class
  2. Fundacion Clinica Valle del Lili · 1 drug in this class
  3. Montefiore Medical Center · 1 drug in this class
  4. Rhode Island Hospital · 1 drug in this class
  5. Rigshospitalet, Denmark · 1 drug in this class
  6. Seoul National University Hospital · 1 drug in this class
  7. Universidad Nacional de La Plata · 1 drug in this class
  8. University of Nottingham · 1 drug in this class
  9. Dalarna County Council, Sweden · 1 drug in this class
  10. Université du Québec à Trois-Rivières · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). NS infusion — Competitive Intelligence Brief. https://druglandscape.com/ci/ns-infusion. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: